-
2024-512998-27-00
5
2025-02-21
Non-Small Cell Lung Cancer
-
2024-513991-16-00
4
2025-01-17
Pulmonary Hypertension Associated with Interstitial Lung Disease
-
2024-514343-29-00
5
2024-11-19
multiple sclerosis
-
2022-501457-37-00
5
2024-10-28
Myeloid Leukemia in Children with Down Syndrome
-
2023-506334-75-00
5
2024-07-12
Pulmonary Arterial Hypertension
-
2023-508359-38-00
5
2024-06-05
Early-stage Non-squamous Non-small Cell Lung Cancer
-
2022-500571-32-00
4
2024-05-15
Early-Stage Unfavorable Classical Hodgkin Lymphoma
-
2023-506669-70-00
5
2024-04-30
Adults with Transthyretin Amyloid Cardiomyopathy (ATTR-CM).
-
2023-505863-35-00
4
2024-03-20
EGFR-mutated Advanced or Metastatic Non-small Cell Lung Cancer
-
2023-506393-12-00
1
2024-02-13
Advanced non-small cell lung cancer
-
2023-503575-21-00
5
2024-01-23
Non-Small Cell Lung Cancer Harboring EGFR Exon 20 Insertion Mutations
-
2023-503428-24-00
4
2024-01-19
Neoplasms, Head and Neck
-
2023-506008-20-00
3
2024-01-11
Extensive-stage small cell lung carcinoma (ES-SCLC)
-
2022-502010-85-00
9
2023-12-20
Non-Squamous Non-Small Cell Lung Cancer
-
2023-503952-28-00
4
2023-11-13
Steroid refractory Acute Graft versus host Disease
-
2022-500802-16-00
5
2023-11-01
Advanced or Metastatic PD-L1 TPS <50% Non-squamous Non-small Cell Lung
-
2022-501176-26-00
5
2023-08-04
Acute Ischemic Stroke and High-Risk Transient Ischemic Attack
-
2024-516536-10-00
4
2023-05-25
Locally advanced head and neck squamous cell carcinoma
-
2022-502634-52-00
5
2023-05-16
prostate cancer
-
2022-501939-16-00
5
2023-05-09
Heart failure (HF) with mildly reduced ejection fraction (HFmrEF) or H
-
2022-501201-13-00
4
2023-03-01
Pulmonary hypertension associated with chronic obstructive pulmonary d
-
2024-514173-22-00
5
2023-02-28
Cystic Fibrosis
-
2022-501901-10-00
6
2023-02-06
Chronic Hepatitis D Infection
-
2024-511625-55-00
6
2022-11-30
EGFRmutated/T790M Mutation negative non-squamous NSCLC